1. 2225 Prediction of tumor response and survival using 18F-fluorodeoxyglucose PET in trimodality therapy for esophageal squamous cell carcinoma. (September 2015) Authors: Hamai, Y.; Hihara, J.; Furukawa, T.; Yamakita, I.; Kurokawa, T.; Okada, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer. Issue 4 (11th March 2014) Authors: Hamai, Y.; Hihara, J.; Taomoto, J.; Yamakita, I.; Ibuki, Y.; Okada, M. Journal: Diseases of the esophagus Issue: Volume 28:Issue 4(2015) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer. Issue 4 (1st June 2015) Authors: Hamai, Y.; Hihara, J.; Taomoto, J.; Yamakita, I.; Ibuki, Y.; Okada, M. Journal: Diseases of the esophagus Issue: Volume 28:Issue 4(2015) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Role of definitive chemoradiotherapy using docetaxel and 5‐fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study. Issue 8 (15th October 2015) Authors: Hihara, J.; Hamai, Y.; Emi, M.; Murakami, Y.; Kenjo, M.; Nagata, Y.; Okada, M. Journal: Diseases of the esophagus Issue: Volume 29:Issue 8(2016) Page Start: 1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗